EIF4E and gastric cancer: Intriguingly, although mTOR/eIF4E pathway was a pivotal driver for EBV‐positive gastric cancer, it also promoted the production of a substantial subset of abnormal W>F peptides, which exposed the fatal drawback of gastric cancer, increasing their susceptibility to the immune system.